Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02972086 · ClinicalTrials.gov registry record · NA

Improving Behavioral Health Care for Children With ADHD

A NA study of ADHD, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
7
Enrollment target
1
Study location

NCT02972086: Completed NA study of ADHD, sponsored by NYU Langone Health.

NCT02972086 is a NA study of ADHD that has completed, run by NYU Langone Health. The registered enrollment target is 7 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02972086, a NA study of ADHD, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is development of the Integrative Pediatric FPA ADHD Care (IPFAC) Model. The IPFAC is intended to increase access to evidence-based behavioral parent training (BPT) for school-age children diagnosed with attention-deficit/hyperactivity disorder(ADHD) who are diagnosed with ADHD and served in the ADHD Clinic at NYU Bellevue's Department of Developmental and Behavioral Pediatrics.

Primary Outcome

Family Practice Associates (FPAs) will provide information on the extent to which the family attended scheduled BPT sessions.

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral Parent Training (BPT)

Study Locations (1)

New York

  • New York University School of Medicine - New York

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2017-01-07
Est. Completion 2017-08-07
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT02972086 record still lists

NCT02972086 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (96% lower).

The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which Behavioral Parent Training (BPT) is the first listed.

NCT02972086 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02972086 about?

NCT02972086 is a clinical study titled "Improving Behavioral Health Care for Children With ADHD". The purpose of this study is development of the Integrative Pediatric FPA ADHD Care (IPFAC) Model. The IPFAC is intended to increase access to evidence-based behavioral parent training (BPT) for school-age children diagnosed with attention-deficit/hyperactivity disorder(ADHD) who are diagnosed with ...

What is the current status of trial NCT02972086?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2017-01-07. Estimated completion is 2017-08-07.

What conditions does trial NCT02972086 study?

This clinical trial studies the following conditions: ADHD.

What interventions are being tested in trial NCT02972086?

The interventions under investigation include: Behavioral Parent Training (BPT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02972086?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02972086 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02972086's enrollment target sits among peer trials

7 74th of 75 higher than 2 of 75 other ADHD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02972086, the US trial registry maintained by the National Library of Medicine. NCT02972086 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.